Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.
2.
3.
4.

Highly specific sites of prolactin binding in benign and malignant breast tissue.

Agarwal PK, Tandon S, Agrawal AK, Kumar S.

Indian J Exp Biol. 1989 Dec;27(12):1035-8.

PMID:
2633963
5.

Antagonism of prolactin binding by cyclosporine A on MCF7 breast tumour cell line.

Bernard DJ, Maurizis JC, Sauvezie B, Bignon YJ, Chassagne J, Chollet P, Plagne R.

Anticancer Res. 1991 Nov-Dec;11(6):2147-51.

PMID:
1776854
6.
7.

Prolactin receptors in human breast tumors.

Turcot-Lemay L, Kelly PA.

J Natl Cancer Inst. 1982 Mar;68(3):381-3.

PMID:
6278192
8.

Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice.

Utama FE, LeBaron MJ, Neilson LM, Sultan AS, Parlow AF, Wagner KU, Rui H.

J Endocrinol. 2006 Mar;188(3):589-601.

9.
10.

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity.

Howell SJ, Anderson E, Hunter T, Farnie G, Clarke RB.

Breast Cancer Res. 2008;10(4):R68. doi: 10.1186/bcr2129. Epub 2008 Aug 5.

11.

Incorporation of alphafetoprotein by the MCF-7 human breast cancer cell line.

Uriel J, Failly-Crepin C, Villacampa MJ, Pineiro A, Geuskens M.

Tumour Biol. 1984;5(1):41-51.

PMID:
6208595
12.
13.

Re-evaluation of the prolactin receptor expression in human breast cancer.

Galsgaard ED, Rasmussen BB, Folkesson CG, Rasmussen LM, Berchtold MW, Christensen L, Panina S.

J Endocrinol. 2009 Apr;201(1):115-28. doi: 10.1677/JOE-08-0479. Epub 2009 Jan 19.

14.

Vitamin D, Pit-1, GH, and PRL: possible roles in breast cancer development.

Perez-Fernandez R, Seoane S, Garcia-Caballero T, Segura C, Macia M.

Curr Med Chem. 2007;14(29):3051-8. Review.

PMID:
18220741
15.

Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography.

Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M.

J Nucl Med. 1996 Apr;37(4):665-72.

16.

Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.

Huang Y, Li X, Jiang J, Frank SJ.

Oncogene. 2006 Dec 7;25(58):7565-76. Epub 2006 Jun 19.

PMID:
16785991
17.
18.
19.

Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop.

Clevenger CV, Chang WP, Ngo W, Pasha TL, Montone KT, Tomaszewski JE.

Am J Pathol. 1995 Mar;146(3):695-705.

20.

Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study.

Gill S, Peston D, Vonderhaar BK, Shousha S.

J Clin Pathol. 2001 Dec;54(12):956-60.

Items per page

Supplemental Content

Write to the Help Desk